1.. Introduction {#S1}
================

Diabetic cardiomyopathy (DCM) is one of the major chronic complications of DM, in which myocardial fibrosis is considered as the main pathological change \[[@ref001]\]. Pathogenesis of myocardial fibrosis is quite complicated, including oxidative stress, inflammatory responses and cell apoptosis. Many studies have confirmed the close correlation between the collagen remodeling in myocardial fibrosis and dysregulation of MMPs/TIMPs expressions. Besides, as a key mediator in fibrosis \[[@ref002]\], CTGF is involved in the fibrotic processes of multiple organs, such as kidney, liver and lung, and, according to some literatures \[[@ref003], [@ref004]\], CTGF also participates in the myocardial fibrosis of DM \[[@ref005]\]. It has been found that H$_{2}$S, as a new gaseous signal molecule, can exert the essential protective effect on cells in cardiovascular diseases. Some research has shown that H$_{2}$S can ameliorate not only the myocardial injuries caused by ischemia reperfusion, but also the myocardial fibrosis under the overloading pressure \[[@ref006]\], whereas the roles and relevant mechanisms of H$_{2}$S in amelioration of myocardial fibrosis of DM remain unclear yet.

It has been reported in some studies that activations of TGF-$\beta$ and MAPK could be induced by high glucose and non-enzymatic advanced glycation end products (AGEs) via DAG-PKC signal pathway and oxidative stress \[[@ref007]\]. PKC, served as the hub of multiple intracellular signal pathways, is involved in the construction of key intracellular information network and regulates a variety of in-vivo physiological and pathological processes. PKC can activate the TGF-$\beta$1 which is one of the key cytokines involved in the pathogenesis \[[@ref008]\], and some studies also reported that ERK1/2 can interact with the TGF-$\beta$1 to be involved in the fibrosis \[[@ref009], [@ref010], [@ref011]\]. Thus, it can be inferred that PKC-ERK1/2MAPK may participate in the myocardial fibrosis pathogenesis in DM, or served as the underlying regulation mechanism, through which H$_{2}$S can ameliorate the myocardial fibrosis in DM. In our research, DM model of rat was established by using STZ for observing the role of H$_{2}$S in attenuating the myocardial fibrosis, and unveiling the regulatory effect of H$_{2}$S on PKC-ERK1/2MAPK signal pathway and the underlying mechanisms to improve the expression dysregulation of MMPs/TIMPs and inflammatory responses.

2.. Material and methods {#S2}
========================

2.1. Experimental animals and reagents {#S2.SS1}
--------------------------------------

The Animal Ethics Committee of University of South China (Hengyang, China) has approved this experimental protocol. Forty male adult SD rats (weighing 280 $\pm$ 20 g), which were purchased from the Animal Experimental Center of University of South China (Hengyang, China) and Animal qualified number is SYXK (hunan) 2015-0006,were fed in a clean laboratory with constant temperature (22 $\pm$ 1$^{\circ}$C) and artificial lighting (day and night 12 h each). Food and water were free to all rats. Streptozotocin (STZ) was provided by MP Biomedicals, LLC (USA), Sodium hydrosulfide (NaHS) was purchased from Sigma-Aldrich LLC (USA). Rabbit polyclonal antibodies against collagen I, collagen III, TGF-$\beta$1, CTGF were purchased from Bioss Biology Company (Beijing, China), rabbit polyclonal antibodies against MMP11, TIMP2, NF-$\kappa$Bp65, TNF-$\alpha$, PPARG, HSP70, HSP90, PKC$\alpha$, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and Anti-rabbit secondary antibody were all provided by Boster Biotechnology (Wuhan, China), and rabbit polyclonal antibody against ERK1/2 was obtained from Cell Signaling Technology (USA). Besides, bicinchoninic acid (BCA) Protein Assay Kit and cell lysis buffer were obtained from Beyotime Company (Shanghai, China).

2.2. Preparation of models {#S2.SS2}
--------------------------

A total of 40 male SD rats were randomly assigned to 4 groups: control group, DM group (STZ group), H$_{2}$S intervention group (STZ $+$ H$_{2}$S group) and H$_{2}$S-control group (H$_{2}$S group). These rats were fed for 1 week to adapt to the environment. After being starved for 12 h, rats received single intraperitoneal injection of STZ (50 mg/kg; STZ being dissolved in citrate buffer; pH $=$ 4.4) to establish the DM model of rat. For establishing the non-DM model of rat, sodium citrate buffer in the same volume was injected intraperitoneally. 72 h later, blood sample was collected from caudal veins, and those rats whose blood glucose level were higher than 16.7 mmol/L were successfully model. NaHS solution (100 $\mu$mol/kg/d) were intraperitoneally injected to the rats in STZ $+$ H$_{2}$S group and H$_{2}$S group, while in control group and STZ group, NaHS solution was replaced by the normal saline in the same volume.

2.3. Extraction of myocardial tissues {#S2.SS3}
-------------------------------------

Eight weeks later, rats were executed immediately followed by thoracotomy to remove the heart. Heart was rinsed using normal saline to purge the residual blood, and the saline on the heart was dried using filter paper. In this study, only left ventricle and interventricular septum were preserved, from which tissues were extracted and then mounted in 10% formaldehyde for Masson staining. Remaining myocardial tissues were preserved in a $-$80$^{\circ}$C refrigerator.

2.4. Observing the myocardial collagen deposition via Masson staining {#S2.SS4}
---------------------------------------------------------------------

The mounted myocardial tissues in left ventricle of rat in 4 groups were regularly embedded using paraffin and sliced into sections followed by Masson staining. Thereafter, tissues were placed under the inverted microscope for observation, in which myocardial cells were in red and collagen fibers in blue.

2.5. Detecting the protein expressions of collagen-I, collagen-III, CTGF and MMPs/TIMPs in myocardial tissues via western blotting {#S2.SS5}
----------------------------------------------------------------------------------------------------------------------------------

Proteins extracted from myocardial tissues in each group were used for quantification via BCA method. Extracted proteins, after being heated for degeneration, were prepared for SDS-PAGE, and then electronically transferred onto the PVDF membrane. After the membrane was blocked using 5% BSA for 2 h, primary antibodies of collagen-I, collagen-III, CTGF, MMPs/TIMPs (diluted at 1:400), and GAPDH (internal reference; diluted at 1:1000) were added onto the membrane for incubation at 37$^{\circ}$C for 1 hour followed by incubation at 4$^{\circ}$C overnight. Thereafter, membrane was taken out and washed using TBST for 3 times. Proteins on the membrane were incubated using HRP-labelled secondary antibodies (diluted at 1:4000) at 37$^{\circ}$C for 1 h. Then, membrane was taken out and washed using TBST for 3 times. After color development using ECL, exposure and scanning, stripes on the membrane were scanned using AlphaImager software, and expression levels of each protein were presented by the ratio of gray value of targeted stripe to that of GAPDH.

2.6. Detecting the protein expressions of TGF-$\beta$1, HSP70, HSP90, NF-$\kappa$Bp65, TNF-$\alpha$ and PPARG in myocardial tissues via western blotting {#S2.SS6}
--------------------------------------------------------------------------------------------------------------------------------------------------------

Samples of myocardial tissues in each group, after being sufficiently grinded, were used for protein quantification. After SDS-PAGE, the proteins were electronically transferred onto a PVDF membrane which was then incubated using the primary antibodies of TGF-$\beta$1, HSP70, HSP90, NF-$\kappa$Bp65, TNF-$\alpha$ and PPARG (diluted at 1:400) and GAPDH (internal reference; diluted at 1:1000). The rest of procedures were the same as the above.

2.7. Detecting the protein expressions of PKC$\alpha$ and ERK1/2 in myocardial tissues via western blotting {#S2.SS7}
-----------------------------------------------------------------------------------------------------------

Proteins extracted from myocardial tissues in each group were used for protein quantification. After SDS-PAGE, the proteins were electronically transferred onto a PVDF membrane which was then incubated using the primary antibodies of PKC$\alpha$, and ERK1/2 (diluted at 1:400) and GAPDH (internal reference; diluted at 1:1000). The rest of procedures were the same as the above.

2.8. Statistical analysis {#S2.SS8}
-------------------------

SPSS 18.0 software was applied to analysis experimental data. Measurement data were presented as mean $\pm$ standard deviation ($\overline{x}$$\pm$$s$). One-way ANOVA was adopted for intergroup comparison. The difference with statistical significance was presented by $p <$ 0.05.

3.. Results {#S3}
===========

3.1. Results of Masson staining {#S3.SS1}
-------------------------------

Masson staining results of myocardial tissues in left ventricle of rat in each group are shown in Fig. [1](#thc-27-thc199029-g001){ref-type="fig"}, in which the blue-stained substance is collagen fiber. Compared to control group, we observed that for rats in the STZ group, myocardium was in malalignment and collagen fiber deposition in matrix obviously increased, suggesting the obvious myocardial fibrosis. However, in comparison with the STZ group, we observed that myocardial arrangement was remarkably ameliorated and the blue-stained collagen fiber deposition was significantly reduced in rats in the STZ $+$ H$_{2}$S group, suggesting the ameliorations in myocardial fibrosis.

Figure 1.Pathological changes of myocardium assessed by Masson staining (Images were obtained at $\times$ 100 magnification).

3.2. Expressions of collagen-I and collagen-III in myocardial tissues of rats {#S3.SS2}
-----------------------------------------------------------------------------

As shown in Fig. [2](#thc-27-thc199029-g002){ref-type="fig"}, comparing to control group, expressions of collagen-I and collagen-III were clearly augmented ($p <$ 0.05) in STZ group. Significant decreases were identified in STZ $+$ H$_{2}$S group when compared to STZ group ($p <$ 0.05). Expression of collagen-I also shows difference between control group and H$_{2}$S group ($p <$ 0.05), however, the expression of collagen-III showed little variation ($p >$ 0.05).

Figure 2.Western blotting results of collagen-I and collagen-III. Data are expressed as mean $\pm$ SD ($n =$ 3). $$ 0.05 *vs* Con group; $$ 0.05 *vs* STZ group.

3.3. Protein expressions of MMP11, TIMP2 and CTGF in myocardial tissues of rats {#S3.SS3}
-------------------------------------------------------------------------------

As shown in Fig. [3](#thc-27-thc199029-g003){ref-type="fig"}, comparing to control group, protein expressions of MMP11, TIMP2 and CTGF were significantly augmented in STZ group ($p <$ 0.05). Significant decreases were identified in the protein expressions of rats in STZ $+$ H$_{2}$S group when comparing to STZ group ($p <$ 0.05). However, no significant variation was detected in the protein expressions of MMP11, TIMP2 and CTGF between control group and H$_{2}$S group ($p >$ 0.05).

Figure 3.Western blotting results of MMP11, TIMP2 and CTGF. Data are expressed as mean $\pm$ SD ($n =$ 3). \*$P <$ 0.05 *vs* Con group; $$ 0.05 *vs* STZ group.

3.4. Protein expressions of TGF-$\beta$1, HSP70, HSP90, NF-$\kappa$Bp65, TNF-$\alpha$ and PPARG in myocardial tissues {#S3.SS4}
---------------------------------------------------------------------------------------------------------------------

As shown in Fig. [4](#thc-27-thc199029-g004){ref-type="fig"}, expressions of TGF-$\beta$1, HSP70, HSP90 and TNF-$\alpha$ were distinctly added in STZ group when compared to control group, and the PPARG was decreased ($p <$ 0.05), while no remarkable change was observed in expression of NF-$\kappa$Bp65. In comparison with STZ group, significant decreases were identified in the expressions of TGF-$\beta$1, HSP70 as well as TNF-$\alpha$ in STZ $+$ H$_{2}$S group, while the PPARG was obviously up-regulated ($p <$ 0.05), and no significant differences were identified in comparison of protein expressions of HSP90 and NF-$\kappa$Bp65 between the two groups ($p >$ 0.05). No significative variation was presented in the protein expressions of the above genes between control group and H$_{2}$S group ($p >$ 0.05).

Figure 4.Western blotting results of TGF-$\beta$1, HSP70, HSP90, NF-$\kappa$Bp65, TNF-$\alpha$ and PPARG. Data are expressed as mean $\pm$ SD ($n =$ 3). \*$P <$ 0.05 *vs* Con group; $$ 0.05 *vs* STZ group, $$ 0.05 *vs* Con group,\*\*$P >$ 0.05 *vs* STZ group.

3.5. Protein expressions of PKC$\alpha$ and ERK1/2 in myocardial tissues of rats {#S3.SS5}
--------------------------------------------------------------------------------

As shown in Fig. [5](#thc-27-thc199029-g005){ref-type="fig"}, protein expressions of PKC$\alpha$ and ERK1/2 were significantly augmented ($p <$ 0.05) in STZ group when compared to control group. Compared with STZ group, significant decreases were identified in the protein expressions of PKC$\alpha$ and ERK1/2 in rats in STZ $+$ H$_{2}$S group ($p <$ 0.05). However, no significant variation was detected in the protein expressions of PKC$\alpha$ and ERK1/2 between control group and H$_{2}$S group ($p >$ 0.05).

Figure 5.Western blotting results of PKC$\alpha$ and ERK1/2. Data are expressed as mean $\pm$ SD ($n =$ 3). \*$P <$ 0.05 *vs* Control group; $$ 0.05. *vs* STZ group.

4.. Discussion {#S4}
==============

DCM is a kind of cardiovascular complications of DM, and as a kind specific cardiomyopathy, it usually has the clinical manifestations in early stage, such as left ventricular hypertrophy and decrease of diastolic function \[[@ref012]\], and its major pathological changes include hypertrophy of myocardial cells and myocardial fibrosis. However, myocardial fibrosis is generally manifested by the excessive deposition of extracellular matrix (ECM), in which dysregulation of MMPs/TIMPs expressions is closely correlated with the deposition of ECM \[[@ref013]\]. MMPs, a kind of Ca$^{2 +}$- and Zn$^{2 +}$-dependent proteinase, can degrade the ECM and basement membrane, while tissue inhibitors of metalloproteinase (TIMPs), as the specific inhibitor of MMPs, can suppress the activity of MMPs; thus, the balanced MMPs/TIMPs expressions are critical to maintaining the regular collagen metabolism and stability of ECM. In this study, when compared to control group, the amount of collage fibers in myocardium of rats in STZ group was significantly increased, and obvious augmentation in expressions of collagen-I and collagen-II was also observed with up-regulation in expressions of MMP11 and TIMP2, suggesting the myocardial fibrosis in DM rats. As a kind of pro-fibrosis factor that has been found in recent years, connective tissue growth factor (CTGF) can strengthen the abilities of fibroblast in mobilization, migration and ECM synthesis \[[@ref014]\], and can be enormously expressed under the induction of TGF-$\beta$1 to participate in the pathogenesis of fibrosis in organs \[[@ref015]\]. TGF-$\beta$1 has been widely recognized as a regulatory factor in close association with the pathogenesis of fibrosis \[[@ref016]\], and not only can it facilitate the transformation of fibroblasts into matrix under the high glucose environment, but also it can boost the synthesis of TIMPs and suppress the degradation of newly synthesized MMPs to reduce collagen degradation and increase collagen deposition \[[@ref017]\]. In this study, the CTGF and TGF-$\beta$1 protein expression in rats of the STZ group was significantly increased, suggested that they may be involved in the dysregulation in MMPs/TIMPs expressions and the pathogenesis of collagen remodeling in DM rats.

Myocardial fibrosis has a very complicated pathogenesis. According to the studies, inflammatory responses caused by high glucose play an important role in the myocardial fibrosis in DM, and the pro-inflammation factors induced by high glucose are critical to the initiation and progression of myocardial fibrosis \[[@ref018], [@ref019]\]. In these factors, TNF-$\alpha$ is involved in the pathogenesis and progression of myocardial fibrosis via multiple pathways, such as facilitating the proliferation of myocardial fibroblasts, inducing the oxidative stress and apoptosis of myocardial cells, enhancing the activity of MMPs and modulating the ECM synthesis. Heat shock protein 70 (HSP70) and HSP90 can reduce the degeneration of proteins under the stress status and eliminate the degenerated or misfolded polypeptides to protect the cells from damages. However, when it comes to abnormal expressions, they could induce the significant up-regulation in expression of TNF-$\alpha$. Peroxisome proliferator-activated receptor $\gamma$ (PPARG) can ameliorate the injuries to elastic fibers through inhibiting the inflammatory responses and protein degradation. In this study, significant myocardial fibrosis was detected in rats in STZ group with the dramatic increases in expressions of HSP70, HSP90 and TNF-$\alpha$ in myocardial tissues in DM rats when compared with control group, and the protein expression of PPARG was also down-regulated, indicating that inflammatory responses participate in the process of myocardial fibrosis in DM rats.

PKC-ERK1/2MAPK signal pathway is involved in the regulation mechanism of inflammatory responses and collagen remodeling in myocardial tissues in DM. PKC is a kind of phospholipid- and Ca$^{2 +}$-dependent protein kinase, and the activation of PKC is a key link in a series of cellular cascade signaling pathway, which can mediate the transmission of various cellular information and participate in the expression and functional modulation of multiple regulation genes. Some studies have demonstrated that PKC participates in the occurrence of myocardial hypertrophy induced by high glucose in diabetic rats \[[@ref020], [@ref021]\], and also can activate the TGF-$\beta$ and MAPK through the DAG-PKC pathway and oxidative stress \[[@ref022], [@ref023]\]; MAPK is a group of highly-preserved serine/threonine kinase in cytoplasm, as one of the three main branches, ERK1/2 are somewhat more specialized for mitogenic and growth factor stimulation when activated \[[@ref024]\], and may be served as the common pathway for vascular complications in DM and pathogenesis in target-organ damages \[[@ref025], [@ref026]\]. Meanwhile, both of the ERK1/2 and TGF-$\beta$1 can generate the positive feedback, in which the activated TGF-$\beta$1 can increase the expression activity, while the activated ERK1/2 can further promote the expression of TGF-$\beta$1. Pan et al. found that TGF-$\beta$1 as well as ERK1/2 were both suppressed when interstitial fibrosis and cardiac dysfunction were alleviated, suggesting that TGF-$\beta$1- ERK1/2 may be critical to the collagen remodeling \[[@ref027]\]. In this study, the protein expressions of PKC, TGF-$\beta$1 and ERK1/2 in the myocardial tissues of rats in the STZ group were significantly up-regulated, revealing that the activation of PKC-ERK1/2MAPK might be associated with the pathological process of myocardial fibrosis in DM.

It has been found that H$_{2}$S, the 3$^{rd}$ newly found endogenous gaseous signal molecule, can protect the heart in a variety of cardiovascular diseases (e.g. the myocardial ischemia reperfusion injuries) through pathways, such as vascular dilation, anti-inflammation, anti-oxidative stress and anti-apoptosis \[[@ref028]\]. There are studies reporting that H$_{2}$S can ameliorate the left ventricular remodeling in hypertension rats \[[@ref029]\]; El-Seweidy et al. also found that H$_{2}$S can improve the myocardial fibrosis \[[@ref030]\]. In this study, results suggested that after the intervention of exogenous H$_{2}$S, deposition of collagen fibers in myocardial matrix of DM rats, the protein expression of CTGF as well as collagen-I and collagen-II were all down-regulated, while the dysregulation in MMPs/TIMPs expressions was abated, prompting that H$_{2}$S can ameliorate the myocardial fibrosis in DM rats. Additionally, our study also presented that comparing to STZ group, the protein expressions of PKC$\alpha$ and ERK1/2 in myocardium of rats in STZ $+$ H$_{2}$S group were down-regulated with the decrease in expressions of HSP70 and TNF-$\alpha$ and the increase in protein expression of PPARG, suggesting that H$_{2}$S may inhibit the inflammatory responses through down-regulating the activities of PKC-ERK1/2MAPK signaling pathway, thus ameliorating the collagen remodeling in myocardial tissues in DM rats. There are also literatures reporting that endogenous or exogenous H$_{2}$S in an appropriate concentration could suppress the inflammatory responses and oxidative stress through regulating the PKC$\alpha$ and extracellular regulated protein kinases to abate the myocardial injuries caused by ischemia or hypoxia and the complications, such as myocardial hypertrophy and fibrosis. In this study, we further confirmed that the mechanism of amelioration in myocardial collagen remodeling in DM via H$_{2}$S might be associated with the regulation of PKC-ERK1/2MAPK signaling pathway. We all know DM is a chronic disease, and the myocardial fibrosis will evolve as time pass by, our research has provided new ideas for intervention in myocardial fibrosis in DM in short term, but more studies will be needed to investigate whether H2S still has positive effects as well as the specific regulation mechanism.
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